CDKN2A and neoplasm: CtBP2 induces the epithelial-to-mesenchymal transition (EMT), helps to repress a number of tumor suppressors (e.g., E-cadherin, PTEN, Ink4 family tumor suppressors), and functions as an antagonist of apoptosis [12, 13].